Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07173985 · ClinicalTrials.gov registry record · NA

Strategies for Optimizing a Mailed FIT Program in Appalachia

A NA study of Colonic Neoplasms, sponsored by Ohio State University Comprehensive Cancer Center.

Recruiting
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT07173985 is a NA study of Colonic Neoplasms that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 500 participants, below the 1,487-participant average among 14 other Colonic Neoplasms trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07173985, a NA study of Colonic Neoplasms, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.

RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

The proposed study is examining strategies for optimizing mailed fecal immunochemical test (FIT) programs. In doing so, it will assess the efficacy of two promising strategies, FIT kit materials and patient navigation delivery mode. These strategies may help to improve colorectal cancer screening rates.

Conditions Studied

Interventions

  • BEHAVIORAL Standard FIT kit
  • BEHAVIORAL Enhanced FIT kit
  • BEHAVIORAL Telephone patient navigation
  • BEHAVIORAL Text message patient navigation

Study Locations (1)

Ohio

  • Ohio State University Comprehensive Cancer Center - Columbus

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2026-01-20
Est. Completion 2028-07-31
Phase NA

What the Registry Record Tells You About NCT07173985

The ClinicalTrials.gov registry entry for NCT07173985 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,487-participant average among 14 other Colonic Neoplasms trials with a reported enrollment target (66% lower). The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Colonic Neoplasms appearing as the primary indexed condition, and to 4 interventions - of which Standard FIT kit is the first listed.

NCT07173985 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT07173985 about?

NCT07173985 is a clinical study titled "Strategies for Optimizing a Mailed FIT Program in Appalachia". The proposed study is examining strategies for optimizing mailed fecal immunochemical test (FIT) programs. In doing so, it will assess the efficacy of two promising strategies, FIT kit materials and patient navigation delivery mode. These strategies may help to improve colorectal cancer screening ra...

What is the current status of trial NCT07173985?

This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2026-01-20. Estimated completion is 2028-07-31.

What conditions does trial NCT07173985 study?

This clinical trial studies the following conditions: Colonic Neoplasms.

What interventions are being tested in trial NCT07173985?

The interventions under investigation include: Standard FIT kit (BEHAVIORAL), Enhanced FIT kit (BEHAVIORAL), Telephone patient navigation (BEHAVIORAL), Text message patient navigation (BEHAVIORAL).

Who is sponsoring clinical trial NCT07173985?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07173985 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colonic Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.